1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMDNeovascular Age-related Macular DegenerationRecruitingPhase 32026-09-21NCT06847542